CD8A and neoplasm: Nonetheless, the evaluation of the intratumoural Neutrophil-to-Lymphocyte Ratio (iNLR), determined by quantifying the intratumoural CD66b + neutrophil to CD8 + T-cell ratio, has identified this cellular marker as an independent predictor of poor outcome regardless of tumour stage in patients with resectable NSCLC [9].